BACKGROUND: During the last two decades, it has become obvious that 3,5-diiodothyronine (3,5-T2), a well-known endogenous metabolite of the thyroid hormones thyroxine (T4) or triiodothyronine (T3), not only represents a simple degradation intermediate of the former but also exhibits specific metabolic activities. Administration of 3,5-T2 to hypothyroid rodents rapidly stimulated their basal metabolic rate, prevented high-fat diet-induced obesity as well as steatosis, and increased oxidation of long-chain fatty acids. OBJECTIVE: The aim of the present study was to analyze associations between circulating 3,5-T2 in human serum and different epidemiological parameters, including age, sex, or smoking, as well as measures of anthropometry, glucose, and lipid metabolism. METHODS: 3,5-T2 concentrations were measured by a recently developed immunoassay in sera of 761 euthyroid participants of the population-based Study of Health in Pomerania. Subsequently, analysis of variance and multivariate linear regression analysis were performed. RESULTS: Serum 3,5-T2 concentrations exhibited a right-skewed distribution, resulting in a median serum concentration of 0.24 nM (1st quartile: 0.20 nM; 3rd quartile: 0.37 nM). Significant associations between 3,5-T2 and serum fasting glucose, thyrotropin (TSH), as well as leptin concentrations were detected (p<0.05). Interestingly, the association to leptin concentrations seemed to be mediated by TSH. Age, sex, smoking, and blood lipid profile parameters did not show significant associations with circulating 3,5-T2. CONCLUSION: Our findings from a healthy euthyroid population may point toward a physiological link between circulating 3,5-T2 and glucose metabolism.
BACKGROUND: During the last two decades, it has become obvious that 3,5-diiodothyronine (3,5-T2), a well-known endogenous metabolite of the thyroid hormones thyroxine (T4) or triiodothyronine (T3), not only represents a simple degradation intermediate of the former but also exhibits specific metabolic activities. Administration of 3,5-T2 to hypothyroid rodents rapidly stimulated their basal metabolic rate, prevented high-fat diet-induced obesity as well as steatosis, and increased oxidation of long-chain fatty acids. OBJECTIVE: The aim of the present study was to analyze associations between circulating 3,5-T2 in human serum and different epidemiological parameters, including age, sex, or smoking, as well as measures of anthropometry, glucose, and lipid metabolism. METHODS:3,5-T2 concentrations were measured by a recently developed immunoassay in sera of 761 euthyroid participants of the population-based Study of Health in Pomerania. Subsequently, analysis of variance and multivariate linear regression analysis were performed. RESULTS: Serum 3,5-T2 concentrations exhibited a right-skewed distribution, resulting in a median serum concentration of 0.24 nM (1st quartile: 0.20 nM; 3rd quartile: 0.37 nM). Significant associations between 3,5-T2 and serum fasting glucose, thyrotropin (TSH), as well as leptin concentrations were detected (p<0.05). Interestingly, the association to leptin concentrations seemed to be mediated by TSH. Age, sex, smoking, and blood lipid profile parameters did not show significant associations with circulating 3,5-T2. CONCLUSION: Our findings from a healthy euthyroid population may point toward a physiological link between circulating 3,5-T2 and glucose metabolism.
Authors: A Antonelli; P Fallahi; S M Ferrari; A Di Domenicantonio; M Moreno; A Lanni; F Goglia Journal: J Biol Regul Homeost Agents Date: 2011 Oct-Dec Impact factor: 1.711
Authors: Henry Völzke; Dietrich Alte; Carsten Oliver Schmidt; Dörte Radke; Roberto Lorbeer; Nele Friedrich; Nicole Aumann; Katharina Lau; Michael Piontek; Gabriele Born; Christoph Havemann; Till Ittermann; Sabine Schipf; Robin Haring; Sebastian E Baumeister; Henri Wallaschofski; Matthias Nauck; Stephanie Frick; Andreas Arnold; Michael Jünger; Julia Mayerle; Matthias Kraft; Markus M Lerch; Marcus Dörr; Thorsten Reffelmann; Klaus Empen; Stephan B Felix; Anne Obst; Beate Koch; Sven Gläser; Ralf Ewert; Ingo Fietze; Thomas Penzel; Martina Dören; Wolfgang Rathmann; Johannes Haerting; Mario Hannemann; Jürgen Röpcke; Ulf Schminke; Clemens Jürgens; Frank Tost; Rainer Rettig; Jan A Kors; Saskia Ungerer; Katrin Hegenscheid; Jens-Peter Kühn; Julia Kühn; Norbert Hosten; Ralf Puls; Jörg Henke; Oliver Gloger; Alexander Teumer; Georg Homuth; Uwe Völker; Christian Schwahn; Birte Holtfreter; Ines Polzer; Thomas Kohlmann; Hans J Grabe; Dieter Rosskopf; Heyo K Kroemer; Thomas Kocher; Reiner Biffar; Ulrich John; Wolfgang Hoffmann Journal: Int J Epidemiol Date: 2010-02-18 Impact factor: 7.196
Authors: Maria Moreno; Elena Silvestri; Rita De Matteis; Pieter de Lange; Assunta Lombardi; Daniela Glinni; Rosalba Senese; Federica Cioffi; Anna Maria Salzano; Andrea Scaloni; Antonia Lanni; Fernando Goglia Journal: FASEB J Date: 2011-06-13 Impact factor: 5.191
Authors: A Lombardi; L Beneduce; M Moreno; S Diano; V Colantuoni; M V Ursini; A Lanni; F Goglia Journal: Endocrinology Date: 2000-05 Impact factor: 4.736
Authors: A Mendoza; P Navarrete-Ramírez; G Hernández-Puga; P Villalobos; G Holzer; J P Renaud; V Laudet; A Orozco Journal: Endocrinology Date: 2013-06-04 Impact factor: 4.736
Authors: Johannes W Dietrich; Patrick Müller; Fabian Schiedat; Markus Schlömicher; Justus Strauch; Apostolos Chatzitomaris; Harald H Klein; Andreas Mügge; Josef Köhrle; Eddy Rijntjes; Ina Lehmphul Journal: Eur Thyroid J Date: 2015-05-23
Authors: Till Ittermann; Roberto Lorbeer; Marcus Dörr; Tobias Schneider; Alexander Quadrat; Lydia Heßelbarth; Michael Wenzel; Ina Lehmphul; Josef Köhrle; Birger Mensel; Henry Völzke Journal: Eur Radiol Date: 2016-03-14 Impact factor: 5.315
Authors: Maik Pietzner; Georg Homuth; Kathrin Budde; Ina Lehmphul; Uwe Völker; Henry Völzke; Matthias Nauck; Josef Köhrle; Nele Friedrich Journal: Eur Thyroid J Date: 2015-05-28
Authors: Till Ittermann; Roberto Lorbeer; Daniel Tiller; Ina Lehmphul; Alexander Kluttig; Stephan B Felix; Karl Werdan; Karin Halina Greiser; Josef Köhrle; Henry Völzke; Marcus Dörr Journal: Eur Thyroid J Date: 2015-05-27
Authors: Rosalba Senese; Pieter de Lange; Giuseppe Petito; Maria Moreno; Fernando Goglia; Antonia Lanni Journal: Front Endocrinol (Lausanne) Date: 2018-07-25 Impact factor: 5.555
Authors: Elena Silvestri; Rosalba Senese; Federica Cioffi; Rita De Matteis; Davide Lattanzi; Assunta Lombardi; Antonia Giacco; Anna Maria Salzano; Andrea Scaloni; Michele Ceccarelli; Maria Moreno; Fernando Goglia; Antonia Lanni; Pieter de Lange Journal: Nutrients Date: 2019-01-27 Impact factor: 5.717